These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 12963615)
1. Status of the NF1 tumor suppressor locus in uveal melanoma. Foster WJ; Fuller CE; Perry A; Harbour JW Arch Ophthalmol; 2003 Sep; 121(9):1311-5. PubMed ID: 12963615 [TBL] [Abstract][Full Text] [Related]
2. Proteomics of uveal melanomas suggests HSP-27 as a possible surrogate marker of chromosome 3 loss. Coupland SE; Vorum H; Mandal N; Kalirai H; Honoré B; Urbak SF; Lake SL; Dopierala J; Damato B Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):12-20. PubMed ID: 19643972 [TBL] [Abstract][Full Text] [Related]
3. Status of RASSF1A in uveal melanocytes and melanoma cells. Calipel A; Abonnet V; Nicole O; Mascarelli F; Coupland SE; Damato B; Mouriaux F Mol Cancer Res; 2011 Sep; 9(9):1187-98. PubMed ID: 21788308 [TBL] [Abstract][Full Text] [Related]
4. Expression of p53-induced apoptosis effector PERP in primary uveal melanomas: downregulation is associated with aggressive type. Paraoan L; Gray D; Hiscott P; Ebrahimi B; Damato B; Grierson I Exp Eye Res; 2006 Oct; 83(4):911-9. PubMed ID: 16784742 [TBL] [Abstract][Full Text] [Related]
5. NF1 and Neurofibromin: Emerging Players in the Genetic Landscape of Desmoplastic Melanoma. Mahalingam M Adv Anat Pathol; 2017 Jan; 24(1):1-14. PubMed ID: 27941538 [TBL] [Abstract][Full Text] [Related]
6. High frequency of submicroscopic hemizygous deletion is a major mechanism of loss of expression of PTEN in uveal melanoma. Abdel-Rahman MH; Yang Y; Zhou XP; Craig EL; Davidorf FH; Eng C J Clin Oncol; 2006 Jan; 24(2):288-95. PubMed ID: 16344319 [TBL] [Abstract][Full Text] [Related]
7. A novel diagnostic method to detect truncated neurofibromin in neurofibromatosis 1. Esposito T; Piluso G; Saracino D; Uccello R; Schettino C; Dato C; Capaldo G; Giugliano T; Varriale B; Paolisso G; Di Iorio G; Melone MA J Neurochem; 2015 Dec; 135(6):1123-8. PubMed ID: 26478990 [TBL] [Abstract][Full Text] [Related]
11. Cripto-1 expression in uveal melanoma: an immunohistochemical study. Mallikarjuna K; Vaijayanthi P; Krishnakumar S Exp Eye Res; 2007 Jun; 84(6):1060-6. PubMed ID: 17412323 [TBL] [Abstract][Full Text] [Related]
12. Epigenetic regulation identifies RASEF as a tumor-suppressor gene in uveal melanoma. Maat W; Beiboer SH; Jager MJ; Luyten GP; Gruis NA; van der Velden PA Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1291-8. PubMed ID: 18385040 [TBL] [Abstract][Full Text] [Related]
13. Mutational analysis of selected genes in the TGFbeta, Wnt, pRb, and p53 pathways in primary uveal melanoma. Edmunds SC; Kelsell DP; Hungerford JL; Cree IA Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):2845-51. PubMed ID: 12202501 [TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor-1 receptor in uveal melanoma: a predictor for metastatic disease and a potential therapeutic target. All-Ericsson C; Girnita L; Seregard S; Bartolazzi A; Jager MJ; Larsson O Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):1-8. PubMed ID: 11773005 [TBL] [Abstract][Full Text] [Related]
16. Oncogenic G Protein GNAQ Induces Uveal Melanoma and Intravasation in Mice. Huang JL; Urtatiz O; Van Raamsdonk CD Cancer Res; 2015 Aug; 75(16):3384-97. PubMed ID: 26113083 [TBL] [Abstract][Full Text] [Related]
17. Epigenetics, microRNAs, and carcinogenesis: functional role of microRNA-137 in uveal melanoma. Chen X; Wang J; Shen H; Lu J; Li C; Hu DN; Dong XD; Yan D; Tu L Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1193-9. PubMed ID: 21051724 [TBL] [Abstract][Full Text] [Related]
18. Bone morphogenetic protein 7 inhibits tumor growth of human uveal melanoma in vivo. Notting I; Buijs J; Mintardjo R; van der Horst G; Vukicevic S; Lowik C; Schalij-Delfos N; Keunen J; van der Pluijm G Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):4882-9. PubMed ID: 17962434 [TBL] [Abstract][Full Text] [Related]
19. Prevalence and implications of TERT promoter mutation in uveal and conjunctival melanoma and in benign and premalignant conjunctival melanocytic lesions. Koopmans AE; Ober K; Dubbink HJ; Paridaens D; Naus NC; Belunek S; Krist B; Post E; Zwarthoff EC; de Klein A; Verdijk RM; Invest Ophthalmol Vis Sci; 2014 Aug; 55(9):6024-30. PubMed ID: 25159205 [TBL] [Abstract][Full Text] [Related]
20. Expression of angiogenic factors Cyr61 and tissue factor in uveal melanoma. Walker TM; Van Ginkel PR; Gee RL; Ahmadi H; Subramanian L; Ksander BR; Meisner LF; Albert DM; Polans AS Arch Ophthalmol; 2002 Dec; 120(12):1719-25. PubMed ID: 12470148 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]